Detalhe da pesquisa
1.
The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.
Am J Pathol;
185(2): 409-19, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25592258
2.
Anti-Pneumococcal Capsular Polysaccharide Antibody Response and CD5 B Lymphocyte Subsets.
Infect Immun;
83(7): 2889-96, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25939510
3.
Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype.
Blood;
121(26): 5176-83, 2013 Jun 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23613519
4.
Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.
Immunology;
138(1): 47-56, 2013 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23039249
5.
Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells.
Front Immunol;
14: 1165936, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37492569
6.
HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G.
J Antimicrob Chemother;
67(5): 1075-9, 2012 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22331593
7.
Molecular detection of SARS-COV-2 in exhaled breath at the point-of-need.
Biosens Bioelectron;
217: 114663, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36150327
8.
Response: Extended analysis of microarray data does not contradict preplasmablast phenotype of human CD20+CD27+CD43+ cells.
Blood;
122(22): 3693-4, 2013 Nov 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24263959
9.
Novel recombinant virus assay for measuring susceptibility of human immunodeficiency virus type 1 group M subtypes to clinically approved drugs.
J Clin Microbiol;
47(7): 2232-42, 2009 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19403770
10.
A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.
J Virol Methods;
153(2): 176-81, 2008 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18706932
11.
Human CD20+CD43+CD27+CD5- B cells generate antibodies to capsular polysaccharides of Streptococcus pneumoniae.
J Allergy Clin Immunol;
130(1): 272-5, 2012 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22664161
12.
The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirtide resistance levels of common enfuvirtide resistance mutations that did not impact susceptibility to sifuvirtide.
Antiviral Res;
86(3): 253-60, 2010 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20227441
13.
Comment on "pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19(+)CD20(+)CD3(-)CD70(-)CD27(+)IgM(+)CD43(+)CD5(+/-)".
Vaccine;
32(25): 2940-1, 2014 May 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24183980
14.
Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.
J Clin Virol;
44(4): 325-8, 2009 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19237313
15.
Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.
Virology;
382(1): 10-9, 2008 Dec 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18930512
16.
Impact on replicative fitness of the G48E substitution in the protease of HIV-1: an in vitro and in silico evaluation.
J Acquir Immune Defic Syndr;
48(3): 255-62, 2008 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18545158